Qsemble Capital Management LP acquired a new stake in Danaher Co. (NYSE:DHR – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,997 shares of the conglomerate’s stock, valued at approximately $555,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Private Trust Co. NA boosted its holdings in shares of Danaher by 2.7% during the 3rd quarter. Private Trust Co. NA now owns 5,459 shares of the conglomerate’s stock worth $1,518,000 after buying an additional 141 shares during the period. Canton Hathaway LLC boosted its holdings in shares of Danaher by 1.5% during the 3rd quarter. Canton Hathaway LLC now owns 11,725 shares of the conglomerate’s stock worth $3,260,000 after buying an additional 175 shares during the period. Truvestments Capital LLC bought a new stake in shares of Danaher during the 3rd quarter worth about $110,000. Loomis Sayles & Co. L P boosted its holdings in shares of Danaher by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 961,226 shares of the conglomerate’s stock worth $267,240,000 after buying an additional 16,740 shares during the period. Finally, Blue Whale Capital LLP boosted its holdings in shares of Danaher by 39.9% during the 3rd quarter. Blue Whale Capital LLP now owns 259,466 shares of the conglomerate’s stock worth $72,137,000 after buying an additional 73,966 shares during the period. Institutional investors own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently commented on DHR shares. Wells Fargo & Company started coverage on shares of Danaher in a report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 target price for the company. Raymond James reduced their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Royal Bank of Canada dropped their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Finally, Stephens reiterated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.
Danaher Trading Up 1.0 %
Shares of Danaher stock opened at $238.90 on Thursday. The firm has a market capitalization of $172.55 billion, a PE ratio of 45.59, a price-to-earnings-growth ratio of 4.37 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm’s 50 day moving average is $256.00 and its 200 day moving average is $259.66. Danaher Co. has a 1 year low of $215.68 and a 1 year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.02 EPS. Equities research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current fiscal year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- Investing in the High PE Growth Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Monster Growth Stocks to Buy Now
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.